Public concern about influenza, or ‘flu’, has amplified over recent years. This serious infection of the respiratory tract is highly contagious and can affect millions of people every year.

The ‘flu’ virus is spread from person to person by coughing and sneezing. The seasonal disease affects all age groups and causes moderate to severe illness, absenteeism and can lead to complications such as pneumonia, hospitalisations and thousands of mortalities worldwide.

The impact of influenza on society has long been underestimated. Solvay Pharmaceuticals is marketing and developing vaccines in order to play a prominent role in the control of this malady.